These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17298437)

  • 1. A metabolomics perspective of human brain tumours.
    Griffin JL; Kauppinen RA
    FEBS J; 2007 Mar; 274(5):1132-9. PubMed ID: 17298437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour metabolomics in animal models of human cancer.
    Griffin JL; Kauppinen RA
    J Proteome Res; 2007 Feb; 6(2):498-505. PubMed ID: 17269706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into cardiovascular and lipid metabolomics.
    Giovane A; Balestrieri A; Napoli C
    J Cell Biochem; 2008 Oct; 105(3):648-54. PubMed ID: 18729082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vivo magnetic resonance spectroscopy].
    Bakken IJ; Skjetne T; Gribbestad IS; Kvistad KA
    Tidsskr Nor Laegeforen; 2002 May; 122(14):1365-8. PubMed ID: 12098905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and statistical approaches to metabolomics research.
    Issaq HJ; Van QN; Waybright TJ; Muschik GM; Veenstra TD
    J Sep Sci; 2009 Jul; 32(13):2183-99. PubMed ID: 19569098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T.
    Sjøbakk TE; Johansen R; Bathen TF; Sonnewald U; Kvistad KA; Lundgren S; Gribbestad IS
    BMC Cancer; 2007 Jul; 7():141. PubMed ID: 17662122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications.
    Soares DP; Law M
    Clin Radiol; 2009 Jan; 64(1):12-21. PubMed ID: 19070693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining nuclear magnetic resonance spectroscopy and mass spectrometry in biomarker discovery.
    Gowda GA; Ijare OB; Shanaiah N; Bezabeh T
    Biomark Med; 2009 Jun; 3(3):307-22. PubMed ID: 20477478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways.
    Xu EY; Schaefer WH; Xu Q
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):40-52. PubMed ID: 19152212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectroscopic magnetic resonance imaging of the brain: voxel localisation and tissue segmentation in the follow up of brain tumour.
    Poloni G; Bastianello S; Vultaggio A; Pozzi S; Maccabelli G; Germani G; Chiarati P; Pichiecchio A
    Funct Neurol; 2008; 23(4):207-13. PubMed ID: 19331784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
    Booth SJ; Pickles MD; Turnbull LW
    BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting.
    van der Kooy F; Maltese F; Choi YH; Kim HK; Verpoorte R
    Planta Med; 2009 Jun; 75(7):763-75. PubMed ID: 19288400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear discriminant analysis of brain tumour (1)H MR spectra: a comparison of classification using whole spectra versus metabolite quantification.
    Opstad KS; Ladroue C; Bell BA; Griffiths JR; Howe FA
    NMR Biomed; 2007 Dec; 20(8):763-70. PubMed ID: 17326043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies.
    Tzika AA; Astrakas L; Cao H; Mintzopoulos D; Andronesi OC; Mindrinos M; Zhang J; Rahme LG; Blekas KD; Likas AC; Galatsanos NP; Carroll RS; Black PM
    Int J Mol Med; 2007 Aug; 20(2):199-208. PubMed ID: 17611638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization of human brain and kidney tissues by magnetic resonance spectroscopy.
    Tugnoli V; Tosi MR
    Ital J Biochem; 2003 Jun; 52(2):80-6. PubMed ID: 14677424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1H NMR, GC-EI-TOFMS, and data set correlation for fruit metabolomics: application to spatial metabolite analysis in melon.
    Biais B; Allwood JW; Deborde C; Xu Y; Maucourt M; Beauvoit B; Dunn WB; Jacob D; Goodacre R; Rolin D; Moing A
    Anal Chem; 2009 Apr; 81(8):2884-94. PubMed ID: 19298059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.